Inhibition of receptor/G protein coupling by suramin analogues

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 415-423

  Beindl, Wolfgang ^a   Mitterauer, Thomas ^a   Hohenegger, Martin ^a   Ijzerman, Adriaan P ^b   Nanoff, Christian ^a   Freissmuth, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; NF 007; NF 018; NF 023; NF 037; SURAMIN; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ARTICLE; BINDING COMPETITION; BRAIN MEMBRANE; COMPETITIVE INHIBITION; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; RECEPTOR OCCUPANCY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BENZAMIDES; GTP-BINDING PROTEINS; HUMANS; PHENYLISOPROPYLADENOSINE; PYRROLIDINES; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP; SURAMIN; XANTHINES;

EID: 0029830693     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hepler, J., and A. G. Gilman. G proteins. Trends Biochem. Sci. 17:383-387 (1992).
2. Milligan, G. Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14:239-244 (1993).
3. Offermanns, S., and G. Schultz. Complex information processing by the transmembrane signaling system involving G proteins. Naunyn Schmiedebergs Arch. Pharmacol. 350:329-338 (1994).
4. sα in Escherichia coli; purification and characterization of two forms of the protein. J. Biol. Chem. 264:409-418 (1989).
5. Inuiguez-Lluhi, J. A., M. I. Simon, J. D. Robishaw, and A. G. Gilman. G protein βγ-subunits synthesized in SF9-cells: functional characterization and the significance of prenylation of γ. J. Biol. Chem. 267:23409-23417 (1992).
6. Wickman, K. D., J. A. Inuiguez-Lluhi, P. A. Davenport, R. Taussig, G. B. Krapivinsky, M. E. Linder, A. G. Gilman, and D. E. Clapham. Recombinant G protein βγ-subunits activate the muscarmic gated atrial potassium channel. Nature (Lond.) 368:255-257 (1994).
7. Taussig, R., W. J. Tang, J. R. Hepler, and A. G. Gilman. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J. Biol. Chem. 269:6093-6100 (1994).
8. 2-dopamine receptor in a reconstituted system. J. Biol. Chem. 265: 4507-4514 (1990).
9. 2-adrenergic receptors subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 30:3335-3341 (1991).
10. 1-adenosine receptor with recombinant G protein α-subunits. J. Biol. Chem. 266:17778-17783 (1991).
11. Bertin, B., M. Freissmuth, R. Breyer, W. Schütz, S. Marullo, and A. D. Strosberg. Functional expression of the human 5-HT1a receptor in Escherichia coli: ligand binding properties and interaction with recombinant G protein α-subunits. J. Biol. Chem. 267:8200-8206 (1992).
12. i3. Biochem. J. 284:565-568 (1992).
13. Fawzi, A. B., D. S. Fay, E. A. Murphy, H. Tamir, J. J. Erdos, and J. K. Northup. Rhodopsin and the retinal G protein distinguish among G protein βγ subunit forms. J. Biol. Chem. 266:12194-12200 (1991).
14. Müller, S., M. Hekman, and M. J. Lohse. Specific enhancement of β-adrenergic receptor kinase activity by defined G protein β- and γ-subunits. Proc. Natl. Acad. Sci. USA 90:10439-10443 (1993).
15. Kleuss, C., H. Scherübl, J. Hescheler, G. Schultz, and B. Wittig. Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature (Lond.) 353:43-48 (1991).
16. Kleuss, C., H. Scherübl, J. Hescheler, G. Schultz, and B. Wittig. Different β-subunits determine G protein interactions with transmembrane receptors. Nature (Lond.) 358:424-426 (1992).
17. Kleuss, C., H. Scherübl, J. Hescheler, G. Schultz, and B. Wittig. Selectivity in signal transduction determined by γ-subunits of heterotrimeric G proteins. Science (Washington D. C.) 259:832-834 (1993).
18. Freissmuth, M., S. Boehm, W. Beindl, P. Nickel, A. P. IJzerman, M. Hohenegger, and C. Nanoff. Suramin analogues as subtype-selective G protein inhibitors. Mol. Pharmacol. 49:602-611 (1996).
19. 1-adenosine receptor. J. Biol. Chem. 269:32077-32084 (1994).
20. 125I]hydroxyphenyliso-propyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding. Mol. Pharmacol 26: 414-423 (1984).
21. 2-purinoceptors. Eur. J. Pharmacol. 268:1-7 (1994).
22. 1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex. Mol. Pharmacol. 48:806-817 (1995).
23. 1-adenosine receptors with G proteins. Biochem. J. 276:651-656 (1991).
24. Freissmuth, M., E. Selzer, S. Marullo, W. Schütz, and A. D. Strosberg. Expression of two human β-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc. Natl. Acad. Sci. USA 88:8548-8552 (1991).
25. Schütz W., and M. Freissmuth. Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci. 13:376-380 (1992).
26. Lefkowitz, R. J., S. Cotecchia, P. Sanama, and T. Costa. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:303-307 (1993).
27. 1-adenosine receptor mediates specific agonist binding. J. Biol. Chem. 269:2373-2376 (1994).
28. Olah, M. E., K. A. Jacobson, and G. Stiles. Identification of an adenosine receptor domain specifically involved in binding of 5′-substituted adenosine agonists. J. Biol. Chem. 269:18016-18020 (1994).
29. Conklin, B. R., and H. R. Bourne. Structural elements of G α-subunits that interact with G βγ-subunits, receptors and effectors. Cell 73:631-641 (1993).
30. Noel, J. P., H. E. Hamm, and P. B. Sigler. The 2.2 65 crystal structure of transducin-α complexed with GTPγS. Nature (Lond.) 366:654-663 (1993).
31. Lambright, D. G., J. P. Noel, H. E. Hamm, and P. B. Sigler. Structural determinants for activation of the α-subunit of a heterotrimeric G protein. Nature (Lond.) 369:621-628 (1994).
32. iα-1 and the mechanism of GTP hydrolysis. Science (Washington D. C.) 265:1405-1412 (1994).
33. Huang, R.-R. C., R. N. Dehaven, A. H. Cheung, R. E. Diehl, R. A. F. Dixon, and C. D. Strader. Identification of allosteric antagonists of receptor-guanine nucleotide binding protein interactions. Mol. Pharmacol. 37:304-310 (1990).
34. Butler, S., E. C. H. Kelly, F. McKenzie, S. Guild, M. O. Wakelam, and G. Milligan. Differential effects of suramin on the coupling of receptors to individual species of pertussis toxin-sensitive guanine nucleotide binding proteins. Biochem. J. 251:201-205 (1988).
35. Neubig, R. R. Membrane organization in G protein mechanisms. FASEB J. 8:939-946 (1994).
36. Voogd, T. E., E. L. M. Vansterkenburg, J. Wilting, and L. H. M. Janssen. Recent research on the biological activity of suramin. Pharmacol. Rev. 45:177-203 (1993).
37. Coffey, R., E. Leof, G. Shipley, and H. Moses. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell. Physiol. 132:143-148 (1987).
38. Williams, L. T., P. M. Tremble, M. F. Lavin, and A. E. Sunday. Platelet-derived growth factor receptors form a high-affinity state in membrane preparations: kinetics and affinity cross-linking studies. J. Biol. Chem. 259:5287-5294 (1984).
39. Mills, G., N. Zhang, C. May, M. Hill, and A. Chung. Suramin prevents binding of interleukin-2 to its cell surface receptor: a possible mechanism for immunosuppression. Cancer Res. 50:3036-3042 (1990).
40. Pollak, M., and M. Richard. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells. J. Natl. Cancer Inst. 82:1349-1352 (1990).
41. Selzer, E., A. Wilfing, V. Sexl, and M. Freissmuth. Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue. Naunyn Schmiedebergs Arch. Pharmacol. 350:322-328 (1994).
42. Blumer, K. J., and G. L. Johnson. Diversity and function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19:236-240 (1994).
43. Lyons, J., C. A. Landis, G. Harsh, L. Vallar, K. Grünewald, H. Feichtinger, Q. Y. Duh, O. H. Clark, E. Kawasaki, H. R. Bourne, and F. McCormick. Two G protein oncogenes in human endocrine tumors. Science (Washington D. C.) 249:655-659 (1990).
44. Weinstein, L. S., A. Shenker, P. V. Gejman, M. J. Merino, E. Friedman, and A. M. Spiegel. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325:1688-1695 (1991).
45. iα-1 in autonomous adenoma. Proc. Natl. Acad. Sci. USA 90:1609-1613 (1993).
46. La Rocca, R., C. Stein, R. Danesi, C. Jamis-Dow, G. Weiss, and C. Myers. Suramin in adrenal cancer: modulation of steroid production, cytotoxicity in vitro, and clinical antitumor effect. J. Clin. Endocrinol. Metab. 71:497-505 (1990).
47. Vierhapper, H., P. Nowotny, G. Mostbeck, and W. Waldhäusl. Effect of suramin in a patient with adrenocortical carcinoma. Lancet 27:1207-1208 (1989).
48. Dorfinger, K., H. Vierhapper, A. Wilfing, S. Czernin, B. Niederle, P. Nowotny, P., P. Peterlik, W. Waldhäusl, and B. Grubeck-Loebenstein. The effects of suramin on human adrenocortical cells in vitro: suramin inhibits cortisol secretion and adrenocortical cell growth. Metabolism 40:1020-1024 (1991).
49. Marzouk, H., J. Zuyderwrjk, P. Uitterlinden, F. De Jong, F., and S. Lamberts. Suramin prevents ACTH-stimulated corticosterone release by dispersed adrenocortical cells, Endocrinology 126:666-668 (1990).